Синдром обструктивного апноэ во время сна. Механизмы возникновения. Клиническое значение. Связь с сердечно-сосудистыми заболеваниями. Принципы лечения

1. Gastaut H, Tassarini C, Duron B. Etudes polygraphiques des manifestations episodiques (hypnique et respiratoire) du syndrome de Pickwick. Rev Neurol 1965; 112: 568–79.
2. Yung R, Kuhlo W. Neuropsychological studies of abnormal night sleep and the Pickwickian syndrome. Prog Brain Res 1965; 18: 140–59.
3. McGregor MI, Block AJ, Ball WS. Serious complications and sudden death in the Pickwickian syndrome. Johns Hopkins Med J 1970; 126–7: 279–95.
4. Phillipson EA. Wake up, America. A Report of the National Commission on Sleep Disorders Research, 1993.
5. Shahar E, Whitney CW, Redline S et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med. 2001; 163: 19–25.
6. Guilleminault C, Eldridge F, Dement WC. Insomnia with sleep apnea: a new syndrome. Science 1973; 181: 856 8.
7. Finn L, Young T, Palta M, Fryback DG. Sleep-disordered breathing and self-reported general health status in the Wisconsin Sleep Cohort Study. Sleep 1998; 21(7): 701–6.
8. Калинкин А.Л. Синдром обструктивного апноэ сна – фактор риска артериальной гипертензии (обзор). Артериальная гипертензия 2003; 9(2): 37–41.
9. Peppard PE, Young T, Palta MP et al. Longitudinal study of moderate weight change and sleep disordered breathing. JAMA 2000; 282: 3015–21.
10. Lugaresi E, Cirignotta F, Coccagna G, Piana C. Some epidemiological data on snoring and cardiocirculatory disturbances. Sleep 1980; 3(3–4): 221–4.
11. Young T, Palta M, Dempsey J et al. The occurrence of sleep disordered breathing among middle-aged adults. N Engl J Med 1993; 328:1230–5.
12. Lavie P, Ben-Yosef R, Rubin AE. Prevalence of sleep apnea among patients with essential hypertension. Am Heart J 1984; 108: 373–6.
13. Waller P, Bhopal RS. Is snoring a cause of vascular disease? Lancet 1989; 1: 143–6.
14. Koskenvuo M, Kaprio J, Telakivi T et al. Snoring as a risk factor for ischemic heart disease and stroke in men. Brit Med J 1987; 294: 16–9.
15. Jennum P, Hein HO, Suadicani P et al. Risk of ischemic heart disease in self-reported snorers. Chest 1995; 108: 138–42.
16. Young T, Peppard PE. Sleep-disordered breathing and cardiovascular disease: epidemiologic evidence for relationship. Sleep 2000; 23: 122–6.
17. Palmer LJ, Buxbau SG, Larkin EK et al. Genome scan for obstructive sleep apnea and obesity in African-American families. Am J Respir Crit Care Med 2004.
18. Вейн А.М., Елигулашвили Т.С., Полуэктов М.Г. Синдром апноэ во сне. М.: Эйдос-Медиа, 2002.
19. Лопатин А.С., Бузунов Р.В., Смушко А. М. и др. Храп и синдром обструктивного апноэ во сне. Рос. ринол. 1998; 4: 17–32.
20. Вейн А.М. Медицина сна (лекция). Кремлевская медицина. Клинич. вестн. 1998; 5: 70–2.
21. Hedner J, Ejnell H, Sellgren J et al. Is high and fluctuating muscle-nerve sympathetic activity in the sleep apnea syndrome of pathogenetic importance for the development of hypertension? J Hypertens 1988; 6(4 Suppl.): 5520–37.
22. Baylor P, Mouton A, Shamoon HH, Goebel P. Increased norepinephrine variability in patients with sleep apnea syndrome. Am J Med 1995; 99(6): 611–6.
23. Lin CC, Zan KW, Lin CY. Plasma levels of atrial natriuretic factor in moderate to sever obstructive sleep apnea syndrome. Sleep 1993; 16 (1): 37–9.
24. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983; 52: 490–4.
25. Angell-James JE, DeBurg-Daly C. Cardiovascular responses in apnoeic asphyxia: role of arterial chemoreceptors end the modification of their effects by pulmonary inflation reflex. J Physiol (London) 1969; 201: 87–104.
26. Masuyama S, Shinozaki T, Kohchiyama S et al. Heart rate depression during sleep apnea depends on hypoxic chemosensitivity. A study at high altitude. Am Rev Respir Dis 1990; 141: 39–42.
27. Andreas S, Hajak G, von Breska B et al. Changes in heart rate during obstructive sleep apnoea. Eur Respir J 1992; 5: 853–7.
28. Zwillich C, Devlin T, White PD. Bradycardia during sleep apnea: characteristics and mechanism. J Clin Invest 1982; 69: 1286–92.
29. Leung RST, Bradley TD. Sleep apnea and cardiovasculare disease. Am J Respir Crit Care Med 2001; 164: 2147–65.
30. Ziegler MG, Mills PJ, Loredo JS et al. Effect of continuous positive airway pressure on sympathetic nervous activity in patients with obstructive sleep apnea. Chest 2001; 120: 887–93.
31. Kuna ST, Remmers JE. Pathophysiology and mechanisms of sleep apnea. Abnormalities of respiration during sleep. Orlando: Grune & Stratton. 1986; 63–94.
32. Hoffstein V. Blood pressure, snoring, obesity, and nocturnal hypoxaemia. Lancet 1994; 344: 643–5.
33. Douglas NJ. The sleep apnea / hypopnea syndrome and snoring. ABC of sleep disorders. London: BMJ Publishing group, 1993; 19–22.
34. Houvelingen van KG, van Uffeln R, van Villet ACM. Sleep apnea syndrome (Review). Eur Heart J 1999; 20: 858–66.
35. ASDA. A review: The indications for polysomnography and related procedures. Sleep 1997; 20(6): 423–67.
36. Downey et al. Upper airway resistance syndrome: sick, symptomatic but underrecognised. Sleep 1993; 16(7): 620–3.
37. The international classification of sleep disorders: diagnostic and coding manual. Kansas: Allen Press Inc., 1990.
38. Bokinsky G, Miller M, Ault K et al. Spontaneous platelet activation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a preliminary investigation. Chest 1995; 108: 625–30.
39. Chin K, Ohi M. New insights into the therapy and pathophysiology of patients with obstructive sleep apnea syndrome. Respirology 1998; 3: 139–43.
40. Nieto FJ, Young TB, Lind BK et al. Association of sleep-disordered breathing, sleep apnea and hypertension in a large community-based study. JAMA 2000; 283(14): 1829 836.
41. Netzer N, Werner P, Jochums I et al. Blood flow of the middle cerebral artery with sleep-disordered breathing: correlation with obstructive hypopneas. Stroke 1998; 29(1): 87–93.
42. Friedlander AH, Friedlander IK, Yueh R, Littner MR. The prevalence of carotid atheromas seen on panoramic radiographs of patients with obstructive sleep apnea and their relation to risk factors for atherosclerosis. J Oral Maxillofac Surg 1999; 57(5): 516 21.
43. Wessendorf TE, Teschler H, Wang YM et al. Sleep-disordered breathing among patients with first-ever stroke. J Neurol 2000; 247(1): 41–7.
44. Placidi F, Diomedi M, Cupini LM et al. Impairment of daytime cerebrovascular reactivity in patients with obstructive sleep apnea syndrome. Sleep Res 1998; 7(4): 288–92.
45. Hedner J, Ejnell H, Caidahl K. Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnoea. J Hypertens 1990; 8: 941–6.
46. Guilleminault C, Shiomi T, Stoohs R, Schnittger I. Electrocardiographic studies in adults and children presenting with obstructive sleep apnea or heavy snoring. In: Sleep and cardiorespiratory control. Eds. C.Gaultier, et al. Montrouge: John Libby Eurotext, 1991: 95–103.
47. Niijima M, Kimura H, Edo H et al. Manifestation of pulmonary hypertension during REM sleep in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1999; 159(6): 1766–72.
48. Kang J, Kimura H, Niijima M et al. Nocturnal pulmonary hypertension in patients with obstructive sleep apnea associated with daytime pulmonary hypertension. Nihon Kyobu Shikkan Gakkai Zasshi 1997; 35(11): 1173–8.
49. Cilli A, Tatlicioglu T, Kokturk O. Nocturnal oxygen desaturation in coronary artery disease. Jpn Heart J 1999; 40(1): 23–9.
50. Peker Y, Kraiczi H, Hedner J et al. An independent association between obstructive sleep apnoea and coronary artery disease. Eur Respir J 1999; 14(1): 179–84.
51. Saarelainen S, Lehtimaki T, Jaakkola O et al. Autoantibodies against oxidised low-density lipoprotein in patients with obstructive sleep apnoea. Clin Chem Lab Med 1999; 37(5): 517–20.
52. Brodsky M, Wu D, Denes P et al. Arrhythmias documented by 24 hour continuous electrocardiographic monitoring in 50 men medical students without apparent heart disease. Am J Cardiol 1977; 39: 390–5.
53. Moss AJ, Hall WJ, Cannom DS et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator trial investigation. N Engl J Med 1996; 335: 1933–40.
54. Shepard Jr JW. Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea. Clin Chest Med 1992; 13: 437–58.
55. Guilleminault C, Connolly SJ, Winkle RA et al. Cyclical variation of the hart rate in sleep apnoea syndrome. Mechanisms and usefulness of 24 h electrocardiography as a screening technique. Lancet 1984; 53: 126–31.
56. Harbison J, O'Reilly P, MacNicholas WT. Cardiac rhythm disturbances in the obstructive sleep apnoea syndrome: effects of nasal continuous airway pressure therapy. Chest 2000; 118: 591–5
57. Grimm W, Koehler U, Fus E et al. Outcome of patients with sleep apnea-associated severe bradiarrhithmias after continuous positive airway pressure therapy. Am J Cardiol 2000; 86: 688–92.
58. Jung F, DiMarco JP. Treatment strategies for atrial fibrillation. Am J Med 1998; 104: 272–86.
59. Marco T, Gulsby S, Rabben T et al. Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery. Coron Artery Disease 1996; 7: 475–8.
60. Gula LJ, Krahn AD, Skanes AC et al. Clinical relevance of arrhythmias during sleep: guidance for clinicians. Heart 2004; 90: 341–52.

А.Ю.Литвин, И.Е.Чазова

ФГУ РКНПК Федерального агентства по высокотехнологичной медицинской помощи, Москва

________________________________________________

A.Y.Litvin, I.E.Chazova